Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01769768
Title Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Oncology Duarte California 91010 United States Details
University of Kansas Medical Center CBYM338B2203 Kansas City Kansas 66160 United States Details
Massachusetts General Hospital Dana-Farber Cancer Institute Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock Med Ctr Lebanon New Hampshire 03756 United States Details
Hackensack University Medical Center Dept.of HackensackUniv.MedCtr. Hackensack New Jersey 07601 United States Details
University of Pennsylvania--Abramson Cancer Center Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497 United States Details
University of Pittsburgh Cancer Institute UPMC Cancer Pavilion Pittsburgh Pennsylvania 15232 United States Details
Medical University of South Carolina Dept.of Neurosciences/MS Ctr. Charleston South Carolina 29425 United States Details
Cancer Centers of the Carolinas SC Greenville South Carolina 29605 United States Details
Utah Health Science Center at San Antonio San Antonio Texas 78229 United States Details
University of Utah / Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field